Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2024-02-08 00:00:00 ET · period of report 2024-02-06 · accession 0000950170-24-012824 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-08 | 2024-02-06 | KPTI | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $1.59 | -4,012 | 821.5K | -0.5% | -$6,379 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-06 | S | D | 4,012 | $1.59 | 821,453 | D | — | — |